Literature DB >> 12359860

Re: tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.

Victor G Vogel, Joseph P Costantino, D Lawrence Wickerham, Walter M Cronin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12359860     DOI： 10.1093/jnci/94.19.1504

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  6 in total

1.  Optimization of thiazole analogues of resveratrol for induction of NAD(P)H:quinone reductase 1 (QR1).

Authors:  Abdelrahman S Mayhoub; Laura Marler; Tamara P Kondratyuk; Eun-Jung Park; John M Pezzuto; Mark Cushman
Journal:  Bioorg Med Chem       Date:  2012-10-23       Impact factor: 3.641

Review 2.  The role of ductal lavage in the management of women at high risk for breast carcinoma.

Authors:  Seema A Khan
Journal:  Curr Treat Options Oncol       Date:  2004-04

3.  Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer.

Authors:  Elisabeth R Garwood; Anjali S Kumar; Frederick L Baehner; Dan H Moore; Alfred Au; Nola Hylton; Chris I Flowers; Judy Garber; Beth-Ann Lesnikoski; E Shelley Hwang; Olofunmilao Olopade; Elisa Rush Port; Michael Campbell; Laura J Esserman
Journal:  Breast Cancer Res Treat       Date:  2010-01       Impact factor: 4.872

4.  Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation.

Authors:  Gillian Mitchell; Yoland C Antill; William Murray; Judy Kirk; Elizabeth Salisbury; Geoffrey J Lindeman; Juliana Di Iulio; Alvin D Milner; Lisa Devereaux; Kelly-Anne Phillips
Journal:  Breast Cancer Res       Date:  2005-11-14       Impact factor: 6.466

5.  New fluorobenzamidine exerts antitumor activity against breast cancer in mice via pro-apoptotic activity.

Authors:  AbdelRahman B Saleh; Nagwa H Hassan; Mohamed A Ismail; Wael M El-Sayed
Journal:  Discov Oncol       Date:  2022-09-15

6.  Formulation Development for Transdermal Delivery of Raloxifene, a Chemoprophylactic Agent against Breast Cancer.

Authors:  Deepal Vora; Amruta Dandekar; Sonalika Bhattaccharjee; Onkar N Singh; Vivek Agrahari; M Melissa Peet; Gustavo F Doncel; Ajay K Banga
Journal:  Pharmaceutics       Date:  2022-03-20       Impact factor: 6.321
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.